Skip to content
Screener

AnaptysBio, Inc. ANAB Royalty Management Company — General And Administrative Expense

Other segment segments

Biopharma Company
$18.86M

Similar metrics at other companies

Contango Silver & Gold logo
CTGOJoint Venture Company — General And Administrative Expense
$0
Beam Therapeutics logo
BEAMExternal General And Administrative Expenses — General And Administrative Expense
$13.37M+149%
CareCloud, Inc. logo
CCLDMedical Practice Management — General And Administrative Expense
$717K+26.0%
Solid Biosciences Inc. logo
SLDBExternal General And Administrative Expense — General And Administrative Expense
$6.33M+19.9%
Solid Biosciences Inc. logo
SLDBInternal General And Administrative Expense — General And Administrative Expense
$4.73M+40.9%
TRA
TRAXExternal Expenses — General And Administrative Expense
$8.72M+127%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.62B+145%
Enterprise value$1.37B+117%
P/S+1.6×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219515
Line itemBiopharmaRoyalty ManagementTotal
Total R&D33,9553633,991
External G&A(3)8,7213,39812,119
Internal G&A(2)10,1353,94814,083
Total G&A18,8567,34626,202
Total operating expenses52,8117,38260,193
(Loss) income from operations(52,811)18,174(34,637)
Interest income2,3283252,653
Non-cash interest expense(20,859)(20,859)

Item 1. Consolidated Financial Statements

FAQ

What is AnaptysBio, Inc.'s royalty management company — general and administrative expense?
AnaptysBio, Inc. (ANAB) reported royalty management company — general and administrative expense of $7.35M in Q1 2026.
How has AnaptysBio, Inc.'s royalty management company — general and administrative expense changed year-over-year?
AnaptysBio, Inc.'s royalty management company — general and administrative expense increased by 70.2% year-over-year, from $4.32M to $7.35M.
What does royalty management company — general and administrative expense mean?
This metric measures the overhead costs associated with the daily operations, management, and administrative support of the royalty management business segment. It includes expenses such as personnel, legal, and professional services required to maintain the segment's operational infrastructure.

Ask your AI about AnaptysBio, Inc.'s royalty management company — general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude